Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of the Neurological Sciences|October 8, 2014
Laboratory diagnosis of Lyme neuroborreliosis is influenced by the test used: comparison of two ELISAs, immunoblot and CXCL13 testingNora Wutte, Juan Archelos, Brian A Crowe, et al.
Molecular Therapy. Methods & Clinical Development|December 30, 2020
Modulation of the liver immune microenvironment by the adeno-associated virus serotype 8 gene therapy vectorAgostina Carestia, Seok-Joo Kim, Franziska Horling, et al.
Plos One|November 22, 2013
Evaluation of OspA vaccination-induced serological correlates of protection against Lyme borreliosis in a mouse modelMichael G Schwendinger, Maria O'Rourke, Andreas Traweger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2011
A new approach to a Lyme disease vaccineIan Livey, Maria O'Rourke, Andreas Traweger, et al.
Plos One|September 21, 2011
Pre-clinical efficacy and safety of experimental vaccines based on non-replicating vaccinia vectors against yellow feverBirgit Schäfer, Georg W Holzer, Alexandra Joachimsthaler, et al.
Vaccine|December 19, 2009
Seasonal influenza vaccine elicits heterosubtypic immunity against H5N1 that can be further boosted by H5N1 vaccinationAndré van Maurik, Nicolas Sabarth, Helga Savidis Dacho, et al.
European Journal of Immunology|October 9, 2021
The soluble cytoplasmic tail of CD45 regulates T-cell activation via TLR4 signalingAlexander Puck, Sarojinidevi Künig, Madhura Modak, et al.
Vaccine|July 4, 2012
A cell culture-derived whole-virus H5N1 vaccine induces long-lasting cross-clade protective immunity in mice which is augmented by a homologous or heterologous booster vaccinationNicolas Sabarth, Helga Savidis-Dacho, Michael G Schwendinger, et al.
Plos One|February 14, 2014
MVA vectors expressing conserved influenza proteins protect mice against lethal challenge with H5N1, H9N2 and H7N1 virusesAnnett Hessel, Helga Savidis-Dacho, Sogue Coulibaly, et al.
Vaccine|November 9, 2010
Evaluation of the cellular immune responses induced by a non-adjuvanted inactivated whole virus A/H5N1/VN/1203 pandemic influenza vaccine in humansBrian A Crowe, Peter Brühl, Marijan Gerencer, et al.
Pageof 2